Should a 28‑week pregnant patient with known heart disease be admitted to the hospital?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hospital Admission at 28 Weeks for Pregnant Patients with Known Heart Disease

Admission at 28 weeks gestation should be individualized based on specific cardiac risk factors, but is generally NOT routinely indicated for all pregnant women with heart disease; instead, admission is reserved for those with high-risk features including NYHA class III-IV symptoms, severe valvular stenosis, pulmonary hypertension, cyanosis, or signs of decompensation. 1

Risk-Based Admission Criteria

Mandatory Admission Indications at 28 Weeks

The following conditions warrant hospital admission at or around 28 weeks gestation:

  • NYHA functional class III-IV symptoms – These patients have no cardiovascular reserve and are at extremely high risk for decompensation during the peak hemodynamic stress period of 24-32 weeks. 1, 2

  • Severe pulmonary hypertension – Maternal mortality risk reaches 30-50%, making close inpatient monitoring essential during the critical second-to-third trimester transition. 2

  • Cyanotic heart disease with oxygen saturation <85% – Fetal growth monitoring becomes critical as growth typically slows and ceases before term in cyanosed women. 1

  • Severe aortic stenosis (mean gradient ≥40 mmHg) with symptoms – The fixed obstruction cannot accommodate the 30-50% increase in cardiac output, risking acute hemodynamic collapse. 1, 2

  • Severe mitral stenosis (valve area <1.0 cm²) with persistent symptoms despite medical therapy – The stenotic valve cannot accommodate increased stroke volume, causing sharp rises in transvalvular gradient and precipitating pulmonary edema. 3

  • Aortic root diameter >4.5 cm in Marfan syndrome or >45 mm in other aortopathies – Risk of aortic dissection is 10% during pregnancy in these patients. 1

Outpatient Management with Frequent Monitoring

Lower-risk patients can be managed as outpatients with intensified surveillance:

  • NYHA class I-II with well-controlled cardiac disease – These patients can be followed with monthly or bimonthly clinical and echocardiographic assessments. 4

  • Mild-to-moderate valvular disease without symptoms – Close outpatient monitoring every 2-4 weeks during the peak hemodynamic period (24-32 weeks) is appropriate. 4

  • Repaired congenital heart disease with good functional status – Outpatient management with regular cardiology follow-up is reasonable. 1

Critical Timing Considerations

The 28-week timepoint falls within the highest-risk hemodynamic window (24-32 weeks gestation) when cardiac output peaks at 40-50% above baseline and plasma volume reaches maximum expansion. 1, 2, 3

  • Between 28-32 weeks represents a particularly difficult decision period where fetal viability improves dramatically (neonatal survival rises from <75% before 28 weeks to 95% after 32 weeks), but maternal cardiac stress remains maximal. 1

  • Before 28 weeks, neonatal survival is low (<75%) with high risk of brain damage (10-14%), so cardiac interventions or procedures should be undertaken to postpone delivery if feasible rather than proceeding with early delivery. 1

Multidisciplinary Team Requirements

All high-risk pregnant cardiac patients require management by a specialized pregnancy heart team at a tertiary care center, regardless of admission status. 1, 2

This team must include:

  • Cardiologists with expertise in pregnancy
  • Maternal-fetal medicine specialists
  • Cardiac anesthesiologists
  • Cardiothoracic surgeons (available for emergencies)
  • Neonatologists 1, 4

Common Pitfalls to Avoid

  • Do not delay admission until overt decompensation occurs – Heart failure develops rapidly during the 24-32 week period, and 66% of serious cardiac events occur in the antepartum period. 5, 6

  • Do not attribute new dyspnea or edema solely to "normal pregnancy changes" – These may represent early cardiac decompensation requiring urgent intervention. 4

  • Do not continue ACE inhibitors or ARBs – These must be discontinued immediately due to fetal renal toxicity and teratogenicity. 1, 3

  • Recognize that approximately 49% of serious cardiac events in pregnancy are preventable, with most preventable events (74%) secondary to provider management factors rather than disease progression. 6

Monitoring Protocol for Admitted Patients

For patients admitted at 28 weeks with high-risk cardiac disease:

  • Daily clinical assessment for signs of heart failure (orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, rales). 1

  • Serial echocardiography every 4-8 weeks for those with aortic dilatation or every 2-4 weeks for severe mitral stenosis. 4

  • Continuous fetal monitoring in cyanotic patients, as fetal growth typically slows and ceases before term. 1

  • Optimization of medical therapy with beta-blockers for rate control in mitral stenosis and cautious diuretics for pulmonary congestion. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maternal Cardiac Complications Associated with Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Rheumatic Heart Disease in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Heart Disease Detection and Management in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Preventing Complications in Pregnant Women With Cardiac Disease.

Journal of the American College of Cardiology, 2020

Related Questions

What is the management plan for a pregnant woman with left-sided heart failure?
What are the red flag signs and management options for cardiac disease in pregnancy?
What is the appropriate management for a 30‑week pregnant woman with newly diagnosed systolic heart failure (ejection fraction ~30%) presenting with dyspnea and NYHA class II?
How should I manage a 30‑week‑gestation pregnant woman with symptomatic heart failure (ejection fraction ~30%, NYHA class II dyspnea) who is currently taking losartan, lisinopril, methyldopa, and hydralazine?
What is the modified World Health Organization (WHO) maternal cardiovascular risk classification for a pregnant woman with chronic diastolic heart failure, ejection fraction 45–50 %, grade 3 diastolic dysfunction, and non‑ischemic cardiomyopathy?
What are the treatment options for Behçet’s disease (Behçet syndrome)?
What is the first‑line antibiotic for acute bacterial sinusitis in an adult patient with diabetes?
How should metoprolol be initiated and titrated in an adult with hypertension, angina, atrial arrhythmias, or chronic heart failure, including starting dose, titration increments and intervals, target heart rate and systolic blood pressure, monitoring for bradycardia, hypotension, heart‑failure worsening, and special considerations for elderly or hepatic impairment?
What is the mechanism of action of benzodiazepines as first‑line treatment for acute alcohol withdrawal syndrome?
In an older male patient with typical cardiovascular comorbidities undergoing elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA), is pre‑procedure antiplatelet loading indicated?
What are the current guidelines for diagnosing and managing type 2 myocardial infarction, including evaluation, treatment of precipitating causes, and secondary‑prevention measures?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.